David J Yvars Group Acquires Shares of 20,966 Doximity, Inc. (NASDAQ:DOCS)

David J Yvars Group acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 20,966 shares of the company's stock, valued at approximately $1,119,000. Doximity accounts for approximately 0.7% of David J Yvars Group's portfolio, making the stock its 25th biggest holding.

Several other hedge funds and other institutional investors have also recently modified their holdings of DOCS. FMR LLC increased its position in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company's stock valued at $297,920,000 after purchasing an additional 1,598,602 shares during the last quarter. Lord Abbett & CO. LLC purchased a new stake in shares of Doximity during the 3rd quarter valued at about $29,453,000. Los Angeles Capital Management LLC boosted its holdings in shares of Doximity by 6,242.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company's stock worth $28,359,000 after purchasing an additional 640,612 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Doximity in the third quarter worth about $24,691,000. Finally, Geode Capital Management LLC boosted its position in Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock valued at $124,503,000 after buying an additional 472,565 shares during the period. 87.19% of the stock is owned by institutional investors.

Doximity Trading Up 2.0 %

Shares of DOCS traded up $0.97 during mid-day trading on Tuesday, reaching $50.68. The company's stock had a trading volume of 1,239,841 shares, compared to its average volume of 1,586,568. The stock has a market cap of $9.46 billion, a P/E ratio of 58.25, a PEG ratio of 4.13 and a beta of 1.38. The business has a 50-day simple moving average of $53.40 and a two-hundred day simple moving average of $42.09. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on DOCS. Canaccord Genuity Group lowered shares of Doximity from a "buy" rating to a "hold" rating and lifted their target price for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Raymond James reiterated an "outperform" rating and set a $65.00 price target (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. Baird R W raised Doximity to a "strong-buy" rating in a research report on Tuesday, September 17th. Evercore ISI increased their price target on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Finally, JPMorgan Chase & Co. increased their price target on shares of Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.